Page last updated: 2024-10-22

albuterol and Muscular Atrophy, Spinal

albuterol has been researched along with Muscular Atrophy, Spinal in 7 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Muscular Atrophy, Spinal: A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khirani, S1
Dabaj, I1
Amaddeo, A1
Olmo Arroyo, J1
Ropers, J1
Tirolien, S1
Coudert, V1
Estournet, B1
Fauroux, B1
Quijano-Roy, S1
Pera, MC1
Luigetti, M1
Sivo, S1
Lapenta, L1
Granata, G1
Antonaci, L1
Coratti, G1
Forcina, N1
Pane, M3
Mercuri, E3
Tiziano, FD3
Lomastro, R2
Abiusi, E1
Pasanisi, MB2
Di Pietro, L1
Fiori, S2
Baranello, G1
Angelini, C1
Sorarù, G1
Gaiani, A1
Mongini, T1
Vercelli, L1
Vasco, G1
Vita, G2
Messina, S2
Petillo, R1
Passamano, L1
Politano, L1
Campanella, A1
Mantegazza, R1
Morandi, L2
Mack, SG1
Cook, DJ1
Dhurjati, P1
Butchbach, ME1
Giovannetti, AM1
Černiauskaitė, M1
Bussolino, C1
Leonardi, M1
Pinto, AM1
D'Amico, A1
Angelozzi, C2
Bertini, E1
Neri, G2
Brahe, C2
Borgo, F1
Martella, A1

Trials

2 trials available for albuterol and Muscular Atrophy, Spinal

ArticleYear
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.
    Journal of medical genetics, 2019, Volume: 56, Issue:5

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Biomarke

2019
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design.
    Journal of medical genetics, 2010, Volume: 47, Issue:12

    Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Child; Child, Preschool; Female; Gene Express

2010

Other Studies

5 other studies available for albuterol and Muscular Atrophy, Spinal

ArticleYear
Effect of Salbutamol on Respiratory Muscle Strength in Spinal Muscular Atrophy.
    Pediatric neurology, 2017, Volume: 73

    Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child; Child, Preschool; Female; Humans; Mal

2017
Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?
    Neuromuscular disorders : NMD, 2018, Volume: 28, Issue:10

    Topics: Albuterol; Child; Female; Humans; Male; Middle Aged; Muscular Atrophy, Spinal; Neuromuscular Agents;

2018
Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Albuterol; Bucladesine; Colforsin; Cyclic AMP; Epinephrine; Fibroblasts; Fluorescent Antibody Techni

2014
Perceived efficacy of salbutamol by persons with spinal muscular atrophy: A mixed methods study.
    Muscle & nerve, 2016, Volume: 54, Issue:5

    Topics: Adult; Albuterol; Bronchodilator Agents; Female; Humans; Longitudinal Studies; Male; Middle Aged; Mu

2016
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
    Journal of medical genetics, 2008, Volume: 45, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Cyclic AMP Response Element-Binding Protein; Exons; Fibroblasts

2008